Sign up for this week’s All Access giveaway here!
Marc Hedrick MD, President and CEO of Plus Therapeutics, Inc PSTV, was a guest on Benzinga’s All Access on October 14, 2022.
Plus Therapeutics is developing targeted radiotherapeutics, a novel treatment for cancer. The technology delivers massive amounts of radiation to the tumor, without damaging the healthy cells surrounding the cancer.
Watch the full interview here:
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.